As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off

Kyra Wensley’s doctor fought to keep her on the injectable weight loss medication Zepbound, but Wensley ultimately had to switch to Wegovy, a different GLP-1 agonist, to meet her health plan’s requirements

“With list prices of roughly $1,000 a month, public and private payers are struggling to keep up with ballooning demand for GLP-1 weight loss drugs and in some cases are eliminating or restricting their coverage as a result.”

Continue reading As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off